Metropolitan Life Insurance Company (MetLife)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,540	Closed	-$9.49K	–	2501
2022 Q4	$9.49K	Buy	3,540 +3,411	+2,644%	+$8.99K	﹤0.01%	2296
2022 Q3	$369	Sell	129 -3,167	-96%	-$13.5K	﹤0.01%	2311
2022 Q2	$16.4K	Hold	3,296	–	–	﹤0.01%	2136
2022 Q1	$23.4K	Sell	3,296 -9,995	-75%	-$82.7K	﹤0.01%	2016
2021 Q4	$242K	Hold	13,291	–	–	﹤0.01%	1895
2021 Q3	$260K	Hold	13,291	–	–	﹤0.01%	1892
2021 Q2	$596K	Buy	13,291 +12,075	+993%	+$560K	0.01%	1405
2021 Q1	$61.1K	Buy	1,216 +579	+91%	+$39.5K	﹤0.01%	2518
2020 Q4	$57K	Buy	637 +157	+33%	+$13.2K	﹤0.01%	2465
2020 Q3	$36.7K	Buy	+480	New	+$30.5K	﹤0.01%	2496

Other funds holding CELL

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 20.14% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CELL Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 3,540 shares — an estimated $9.49K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CELL in Q3 2020 and held it in 10 quarters. The position peaked at $596K in Q2 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,540 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $9.49K.
Metropolitan Life Insurance Company (MetLife) first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s PhenomeX Inc. Common Stock position peaked at $596K in Q2 2021.
102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.